CLINICAL AND LABORATORY CHANGES IN THE LIVER THAT DEVELOP AGAINST THE BACKGROUND OF INTESTINAL DYSBACTERIOSIS
Keywords:
dysbiosis, dysbacteriosis, mitochondrial dysfunction, liverAbstract
This article presents information about the clinical signs, laboratory test results, and pathological changes in the liver that occur when intestinal dysbacteriosis occurs, when the balance of intestinal bacteria in the body is disrupted and toxins and inflammatory factors enter the liver through the blood.
References
1. Radchenko VG et al. The treatment algorithm for non-alcoholic fatty liver disease and the role of mitochondrial dysfunction in the development of NAFLD. Pharmatek, 2017, 6: 14-21.
2. Bondarenko VM The role of opportunistic pathogenic bacteria in chronic inflammatory processes of various localizations. Tver: Triada, 2011, 88 p.
3. Bondarenko VM, Matsulevich TV Intestine dysbacteriosis as a clinical and laboratory syndrome: status update on the problem: a guide for practitioners. Moscow: GEOTAR-Media, 2007. 304 p. / Bondarenko VM, Matsulevich TV. Intestine dysbacteriosis as a clinical and laboratory syndrome: status update on the problem: a guide for practitioners. Moscow: GEOTAR-Media, 2007. 304 p.
4. Bondarenko VM Dysbacteriosis. Moscow: Meditsina, 1994, p. 334. / Bondarenko VM Dysbacteriosis. Moscow: Meditsina, 1994, p. 334.
5. Vorobyov AA, Lykova EA Bacteria of normal microflora: biological properties and protective functions. Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii, 1999, 6: 102–105. / Vorobiev AA, Lykova EA. Normal microflora bacteria: biological properties and protective.
6. Vorobiev AA, Nesvizhsky YuV, Zudenkov AE, et al. A comparative study of parietal and luminal colon microflora in an experiment in mice. Zhurn. Mikrobiol., Epidemiol. i Immunobiol., 2001, 1: 62–7.
7. Gabrielyan NI, Gorskaya EM, Snegova ND. Functions of the gastrointestinal tract microflora and consequences of its disorders after surgical interventions. Antibiotics and Chemotherapy, 2000, 9: 24–29. / Gabrielyan NI, Gorskaya EM, Snegova ND. Functions of the gastrointestinal tract microflora and the consequences of its disorders after surgical interventions. Antibiotics and Chemotherapy, 2000, 9: 24–29.
8. Grinevich VB, Uspensky YuP, Dobrynin VM, et al. Clinical aspects of diagnosis and treatment of intestinal dysbiosis in general therapeutic practice. SPb., 2003, p. 36.
9. Sitkin SI et al. Dysbiosis in ulcerative colitis and celiac disease and its therapeutic correction by butyric acid plus inulin. Experimental and Clinical Gastroenterology, 2017, 142(6): 77-98. /Sitkin SI, et al. Dysbiosis in ulcerative colitis and celiac disease and its therapeutic correction by butyric acid plus inulin. Eksp Klin Gastroenterol, 2017,(6):77–98.
10. Erofeev NP, Seliverstov PV, Radchenko VG. Clinical physiology of the colon. Mechanisms of action of short-chain fatty acids in health and pathology. Moscow: OOO 4TE ART, 2012. 56 p. / Erofeev NP, Seliverstov PV, Radchenko VG. Clinical physiology of the colon. Mechanisms of action of short-chain fatty acids in normal and pathological conditions. M.: “4TE ART” LLC, 2012. 56 p.
